{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Armodafinil+250+mg", "query": { "intervention": "Armodafinil 250 mg" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 15, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Armodafinil+250+mg&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-23T12:51:17.689Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00893789", "title": "Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Traumatic Brain Injury" ], "interventions": [ { "name": "Armodafinil", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Cephalon, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 117, "start_date": "2009-04-30", "completion_date": "2011-01-31", "has_results": true, "last_update_posted_date": "2021-12-17", "last_synced_at": "2026-09-23T12:51:17.689Z", "location_count": 68, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Hot Springs, Arkansas + 53 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00893789" }, { "nct_id": "NCT01781468", "title": "Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Fatigue" ], "interventions": [ { "name": "armodafinil 150 mg", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "armodafinil 250 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 328, "start_date": "2013-06-21", "completion_date": "2019-12-15", "has_results": true, "last_update_posted_date": "2025-01-27", "last_synced_at": "2026-09-23T12:51:17.689Z", "location_count": 365, "location_summary": "Anchorage, Alaska • Fairbanks, Alaska • Phoenix, Arizona + 254 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT01781468" }, { "nct_id": "NCT02468856", "title": "Effect of Armodafinil on Simulated Driving", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "armodafinil", "type": "DRUG" }, { "name": "Placebo (for armodafinil)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "18 Years to 35 Years" }, "enrollment_count": 12, "start_date": "2017-05-21", "completion_date": "2017-11-30", "has_results": false, "last_update_posted_date": "2018-12-31", "last_synced_at": "2026-09-23T12:51:17.689Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02468856" }, { "nct_id": "NCT00592943", "title": "PET Study Examining the Dopaminergic Activity of Armodafinil in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "armodafinil", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "18 Years to 35 Years" }, "enrollment_count": 12, "start_date": "2007-10", "completion_date": "2010-05", "has_results": true, "last_update_posted_date": "2013-11-13", "last_synced_at": "2026-09-23T12:51:17.689Z", "location_count": 1, "location_summary": "Cambridge, Massachusetts", "locations": [ { "city": "Cambridge", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00592943" }, { "nct_id": "NCT01096680", "title": "Pharmacodynamic Profile of SPD489 in Healthy Adult Males Undergoing a Nocturnal Period of Acute Sleep Loss", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sleep Deprivation" ], "interventions": [ { "name": "SPD489 20 mg", "type": "DRUG" }, { "name": "SPD489 50 mg", "type": "DRUG" }, { "name": "SPD489 70 mg", "type": "DRUG" }, { "name": "Armodafinil", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "MALE", "summary": "18 Years to 40 Years · Male only" }, "enrollment_count": 135, "start_date": "2010-04-05", "completion_date": "2010-07-18", "has_results": true, "last_update_posted_date": "2021-06-14", "last_synced_at": "2026-09-23T12:51:17.689Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01096680" }, { "nct_id": "NCT00772005", "title": "Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "armodafinil", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cephalon", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 287, "start_date": "2008-09", "completion_date": "2010-05", "has_results": true, "last_update_posted_date": "2012-07-27", "last_synced_at": "2026-09-23T12:51:17.689Z", "location_count": 39, "location_summary": "Little Rock, Arkansas • Anaheim, California • Escondido, California + 32 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Escondido", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00772005" }, { "nct_id": "NCT00236080", "title": "Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Shift Work Sleep Disorder" ], "interventions": [ { "name": "PROVIGIL 200 mg", "type": "DRUG" }, { "name": "Armodafinil 250 mg", "type": "DRUG" }, { "name": "Armodafinil 200 mg", "type": "DRUG" }, { "name": "Armodafinil 150 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cephalon", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 136, "start_date": "2005-08", "completion_date": "2005-12", "has_results": true, "last_update_posted_date": "2013-07-19", "last_synced_at": "2026-09-23T12:51:17.689Z", "location_count": 20, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Hot Springs, Arkansas + 16 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00236080" }, { "nct_id": "NCT00228553", "title": "Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Excessive Daytime Sleepiness", "Narcolepsy", "Obstructive Sleep Apnea/Hypopnea Syndrome", "Chronic Shift Work Sleep Disorder" ], "interventions": [ { "name": "Armodafinil 100 to 250 mg/day", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cephalon", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 743, "start_date": "2004-05", "completion_date": "2006-07", "has_results": true, "last_update_posted_date": "2013-07-19", "last_synced_at": "2026-09-23T12:51:17.689Z", "location_count": 74, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Hot Springs, Arkansas + 64 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00228553" }, { "nct_id": "NCT00983437", "title": "Study to Evaluate the Safety, Tolerability, and Efficacy of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Traumatic Brain Injury" ], "interventions": [ { "name": "Armodafinil", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cephalon, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 49, "start_date": "2009-08-31", "completion_date": "2011-01-31", "has_results": true, "last_update_posted_date": "2021-12-17", "last_synced_at": "2026-09-23T12:51:17.689Z", "location_count": 61, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Hot Springs, Arkansas + 49 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00983437" }, { "nct_id": "NCT00737204", "title": "Effectiveness of Armodafinil for Treating Fatigue in Adults With HIV/AIDS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "HIV Infections", "Fatigue" ], "interventions": [ { "name": "Armodafinil", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "New York State Psychiatric Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 70, "start_date": "2008-06", "completion_date": "2010-09", "has_results": true, "last_update_posted_date": "2014-06-12", "last_synced_at": "2026-09-23T12:51:17.689Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00737204" } ] }